[go: up one dir, main page]

UA92727C2 - Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений - Google Patents

Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений

Info

Publication number
UA92727C2
UA92727C2 UAA200705421A UAA200705421A UA92727C2 UA 92727 C2 UA92727 C2 UA 92727C2 UA A200705421 A UAA200705421 A UA A200705421A UA A200705421 A UAA200705421 A UA A200705421A UA 92727 C2 UA92727 C2 UA 92727C2
Authority
UA
Ukraine
Prior art keywords
prevention
treatment
viral infections
immunomodulator compounds
hemorrhagic viral
Prior art date
Application number
UAA200705421A
Other languages
English (en)
Ukrainian (uk)
Inventor
Эрик С. Моссел
Цинтия В. Татхилл
Альфред Р. Рудолф
Кларенс Джеймс Питерс
Original Assignee
Сайклон Фармасютикалс, Инк.
Дзе Боард Оф Регентс Оф Дзе Юниверсити Оф Техас Систем
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сайклон Фармасютикалс, Инк., Дзе Боард Оф Регентс Оф Дзе Юниверсити Оф Техас Систем filed Critical Сайклон Фармасютикалс, Инк.
Publication of UA92727C2 publication Critical patent/UA92727C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение касается способа лечения пациента, страдающего геморрагической вирусной инфекцией или имеющего риск ее приобрести, которому вводят иммуномодулирующее соединение формулы А:.
UAA200705421A 2004-10-27 2005-10-27 Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений UA92727C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62202204P 2004-10-27 2004-10-27

Publications (1)

Publication Number Publication Date
UA92727C2 true UA92727C2 (ru) 2010-12-10

Family

ID=36228480

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200705421A UA92727C2 (ru) 2004-10-27 2005-10-27 Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений

Country Status (19)

Country Link
US (1) US8193152B2 (ru)
EP (1) EP1814566B1 (ru)
JP (1) JP4874985B2 (ru)
KR (1) KR20070070202A (ru)
CN (1) CN101048171B (ru)
AT (1) ATE475426T1 (ru)
AU (1) AU2005299609A1 (ru)
BR (1) BRPI0517401A (ru)
CA (1) CA2585457A1 (ru)
DE (1) DE602005022612D1 (ru)
EA (1) EA012342B1 (ru)
ES (1) ES2350087T3 (ru)
IL (1) IL182710A (ru)
MX (1) MX2007005092A (ru)
NO (1) NO20072498L (ru)
NZ (1) NZ555322A (ru)
SG (1) SG163601A1 (ru)
UA (1) UA92727C2 (ru)
WO (1) WO2006047702A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090074815A1 (en) * 2005-04-22 2009-03-19 Sciclone Pharmaceuticals, Inc. Immunomodulator Compounds as Vaccine Enhancers
EP2120986A4 (en) * 2007-02-13 2010-04-07 Sciclone Pharmaceuticals Inc METHOD FOR THE TREATMENT OR PREVENTION OF TISSUE WEAR, INJURY OR DAMAGE CAUSED BY SLEWER DISEASES
CA2826875A1 (en) * 2011-02-09 2012-08-16 Sciclone Pharmaceuticals, Inc. Thymosin alpha peptide for preventing, reducing the severity of, and treating infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
UA92586C2 (ru) 2004-05-14 2010-11-25 Сайклон Фармасютикалс, Инк. Лечение или предотвращение респираторных вирусных инфекций с помощью иммуномодуляторов
UA12948U (en) 2005-07-11 2006-03-15 Inst Of Veterinary Medicine Uk Associated inactivated concentrated serdosan vaccine against colibacteriosis, edematous disease, pasteurellosis, salmonellosis, and anaerobic enterotoxicemia of pigs

Also Published As

Publication number Publication date
WO2006047702A2 (en) 2006-05-04
IL182710A0 (en) 2007-07-24
CA2585457A1 (en) 2006-05-04
DE602005022612D1 (de) 2010-09-09
EP1814566B1 (en) 2010-07-28
KR20070070202A (ko) 2007-07-03
ATE475426T1 (de) 2010-08-15
EA012342B1 (ru) 2009-10-30
NO20072498L (no) 2007-05-15
BRPI0517401A (pt) 2008-10-14
SG163601A1 (en) 2010-08-30
ES2350087T3 (es) 2011-01-18
CN101048171B (zh) 2011-02-09
CN101048171A (zh) 2007-10-03
NZ555322A (en) 2009-02-28
JP2008518031A (ja) 2008-05-29
IL182710A (en) 2012-04-30
US8193152B2 (en) 2012-06-05
EP1814566A4 (en) 2008-05-07
US20090143313A1 (en) 2009-06-04
EA200700878A1 (ru) 2007-10-26
MX2007005092A (es) 2007-07-04
WO2006047702A3 (en) 2006-07-20
AU2005299609A1 (en) 2006-05-04
JP4874985B2 (ja) 2012-02-15
EP1814566A2 (en) 2007-08-08

Similar Documents

Publication Publication Date Title
AU2003291885A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
GB0612423D0 (en) Therapeutic agents
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
GB0413087D0 (en) Therapeutic compounds
MX351590B (es) Antibioticos de oxazolidinona.
MX2009006764A (es) Pirimidinonas biciclicas y usos de la misma.
MA32634B1 (fr) Polytherapie destinee a traiter une infection par le vhc
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
NO20065518L (no) Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser.
IL182710A0 (en) Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
SE0200198D0 (sv) New use
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
EA200501569A1 (ru) Лечение или профилактика респираторных вирусных инфекций с использованием пептидов альфа-тимозина
MX2007008585A (es) Compuestos peptidicos.
WO2006076169A3 (en) Treatment or prevention of genital viral infections with immunomodulator compounds
ZA200800999B (en) Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
WO2010019698A3 (en) Inhibition of calicivirus (norovirus)
ATE338545T1 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS